|

Prospective Observational Cohort Study of Cardiac Structure and Function in Children and Adults With Osteogenesis Imperfecta

RECRUITINGSponsored by Istituto Ortopedico Rizzoli
Actively Recruiting
SponsorIstituto Ortopedico Rizzoli
Started2025-06-10
Est. completion2031-12
Eligibility
Age5 Years – 80 Years
Healthy vol.Accepted

Summary

This prospective observational investigation will examine the incidence and progression of cardiologic findings in individuals with OI across different age groups. Cardiopulmonary complications are recognized as major contributors to morbidity and mortality in adults with OI, although life expectancy has significantly improved in recent years due to medical advancements. By systematically evaluating cardiovascular involvement in this population, the study aims to generate clinically relevant evidence to inform early cardiologic screening strategies and support the development of harmonized and targeted management approaches, ultimately improving clinical practice and the quality of life of individuals living with OI.

Eligibility

Age: 5 Years – 80 YearsHealthy volunteers accepted
Inclusion Criteria:

* Diagnosis of OI according to the modified Sillence classification (Mortier et al., 2019)
* All subjects with OI who attend genetic consultations at the clinic affiliated with the Rare Skeletal Diseases Unit of the IRCCS Rizzoli Orthopaedic Institute (IOR)
* Willingness to undergo clinical and instrumental assessments at the IOR

Exclusion Criteria:

* Acute upper and/or lower respiratory tract infections at the time of assessment
* Cognitive impairment affecting cooperation and the performance of examinations

Conditions3

Heart DiseaseOsteogenesis ImperfectaOsteogenesis Imperfecta (OI)

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.